301015SZSE

Announcement on the Resumption of Conversion for Baiyang Convertible Bonds

Qingdao Baheal Medical INC.··1 page

✨ AI Summary

This announcement informs that Baiyang Pharmaceutical Co., Ltd. will resume the conversion of its convertible bonds (code: 123194) on June 1, 2026, after a temporary suspension from May 21 to May 29, 2026, due to the 2025 equity distribution. The conversion period is from October 20, 2023, to April 13, 2029. Bondholders are advised to take note of this resumption.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement on the Resumption of Conversion for Baiyang Convertible Bonds

Securities Code: 301015
Securities Abbreviation: Baiyang Pharmaceutical
Announcement Number: 2026-042
Bond Code: 123194
Bond Abbreviation: Baiyang Convertible Bonds

Qingdao Baiyang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing